Cite

HARVARD Citation

    Kletzl, H. et al. (2022). Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam. British journal of clinical pharmacology. 88 (8), pp. 3749-3759. [Online]. 
  
Back to record